Journal of International Oncology››2012,Vol. 39››Issue (6): 436-439.

Previous ArticlesNext Articles

Hypofractionated radiotherapy for non-small-cell lung cancer

GUAN Shang-hui, LI Cai-yun, CHENG Yu-feng

  1. Department of Radiation Oncology, Qilu Hospital of Shandong University, Jinan 250012, China
  • Online:2012-06-08Published:2012-06-25
  • Contact:CHENG Yu-feng, E-mail: qlcyf@163.com E-mail:qlcyf@163.com

Abstract:Hypofractionated three-dimensional conformal radiotherapy (3DCRT) makes it possible to further improve local control, overall survival and the quality of life for the patients with non-small-cell lung cancer (NSCLC). But the dosefractionation and total dose are not yet clear, which need further study. Hypofractionated stereotactic body radiotherapy (SBRT) for early-stage NSCLC patients is well tolerated and results in excellent local control and overall survival. SBRT is expected to become a new standard treatment in patients with early stage NSCLC.

Key words:Carcinoma, non-small-cell lung,Radiotherapy, comformal,Dose fractionation